Troy L. Holsing

Vice President, Application Development & Chief Technical Officer at Veran Medical Technologies, Inc.

Troy L. Holsing

Troy L. Holsing

Vice President, Application Development & Chief Technical Officer at Veran Medical Technologies, Inc.

Overview
RelSci Relationships

1292

Relationships
RelSci Relationships are individuals Troy L. Holsing likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Vice President-Business Development & Operations at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

President & Director at CardioNXT, Inc.

Relationship likelihood: Strong

Former Vice President-Engineering at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

Vice Chairman at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

Director, Quality & Regulatory at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

Vice President, Sales at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

Former Global Vice President-Marketing at Veran Medical Technologies, Inc.

Relationship likelihood: Average

Education Manager at Veran Medical Technologies, Inc.

Relationship likelihood: Average

Former Chief Financial Officer & Head-Investor Relations at MRI Interventions, Inc.

Relationship likelihood: Average

Paths to Troy L. Holsing
Potential Connections via
Relationship Science
You
Troy L. Holsing
Vice President, Application Development & Chief Technical Officer at Veran Medical Technologies, Inc.
Career History
Vice President, Application Development & Chief Technical Officer
Current

Veran Medical Technologies, Inc. designs, develops and markets soft tissue equipment. The firm's main focus is assisting physicians in the early diagnosis and treatment of lung cancer. It provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The company was founded by Ben Heavrin, Bruce Lynskey and Jerome R. Edwards in 2005 and is headquartered in St. Louis, MO.

Professional
Prior

Sofamor Danek Group, Inc. used to develop, make and market spinal implant devices. The company's products included invasive devices, bone replacement material, interbody fusion devices, surgical navigation technology and hedrocel material. Sofamor Danek was located in Memphis, TN

Senior Manager-Product Development
Prior

Medtronic was founded in 1949 as a medical equipment repair shop by Earl Bakken and his brother-in-law, Palmer Hermundslie. Since then, we've grown into a multinational company that uses technology to transform the way debilitating, chronic diseases are treated.Our first life-changing therapy – a wearable, battery-powered cardiac pacemaker – was the foundation for dozens more Medtronic therapies that use our electrical stimulation expertise to improve the lives of millions of people. Over the years, we adapted additional technologies for the human body, including radio frequency therapies, mechanical devices, drug and biologic delivery devices, and diagnostic tools. Today, our technologies are used to treat more than 30 chronic diseases affecting many areas of the body.

Transactions
Details Hidden

Veran Medical Technologies, Inc. raised money in a private placement transaction

Details Hidden

Veran Medical Technologies, Inc. raised money in a private placement transaction

Details Hidden

Veran Medical Technologies, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Troy L. Holsing. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Troy L. Holsing's profile does not indicate a business or promotional relationship of any kind between RelSci and Troy L. Holsing.